Clinical trial
Pivotal Clinical Study of Endoscopic Ablation for Atrial Fibrillation (AF) in…
NCT00477230 · CardioFocus, Industry · Terminated
Key facts
| NCT number | NCT00477230 |
|---|---|
| Title | Pivotal Clinical Study of Endoscopic Ablation for Atrial Fibrillation (AF) in Patients That Have Failed Drugs |
| Official title | Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System for the Treatment of Symptomatic Atrial Fibrillation (AF) |
| Acronym | ENABLE |
| Lead sponsor | CardioFocus, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Device, Drug |
| Interventions | Endoscopic Ablation System, Standard Anti-arrhythmic Drug (AAD) Therapy |
| Enrollment | 64 |
| Start date | Mar 1, 2007 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2009 |
| First posted | May 23, 2007 |
| Last update posted | Jun 27, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: